vs

Side-by-side financial comparison of COMPUGEN LTD (CGEN) and Camden Property Trust (CPT). Click either name above to swap in a different company.

Camden Property Trust is the larger business by last-quarter revenue ($5.3M vs $3.5M, roughly 1.5× COMPUGEN LTD). Camden Property Trust runs the higher net margin — 2954.1% vs -410.1%, a 3364.2% gap on every dollar of revenue. On growth, Camden Property Trust posted the faster year-over-year revenue change (243.0% vs -61.8%).

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

Camden Property Trust is a publicly traded real estate investment trust that invests in apartments in the United States. As of December 31, 2023, the company owned interests in 176 apartment communities containing 59,800 apartment homes in the United States. It is the 14th largest owner of apartments in the United States.

CGEN vs CPT — Head-to-Head

Bigger by revenue
CPT
CPT
1.5× larger
CPT
$5.3M
$3.5M
CGEN
Growing faster (revenue YoY)
CPT
CPT
+304.8% gap
CPT
243.0%
-61.8%
CGEN
Higher net margin
CPT
CPT
3364.2% more per $
CPT
2954.1%
-410.1%
CGEN

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CGEN
CGEN
CPT
CPT
Revenue
$3.5M
$5.3M
Net Profit
$-14.5M
$156.0M
Gross Margin
Operating Margin
-475.1%
Net Margin
-410.1%
2954.1%
Revenue YoY
-61.8%
243.0%
Net Profit YoY
-54.7%
283.5%
EPS (diluted)
$-0.16
$1.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGEN
CGEN
CPT
CPT
Q4 25
$5.3M
Q3 25
$2.6M
Q2 25
$3.5M
$2.6M
Q1 25
$2.5M
Q4 24
$1.5M
Q3 24
$1.7M
Q2 24
$9.3M
$2.6M
Q1 24
$2.6M
$1.3M
Net Profit
CGEN
CGEN
CPT
CPT
Q4 25
$156.0M
Q3 25
$108.9M
Q2 25
$-14.5M
$80.7M
Q1 25
$38.8M
Q4 24
$40.7M
Q3 24
$-4.2M
Q2 24
$-9.4M
$42.9M
Q1 24
$7.3M
$83.9M
Gross Margin
CGEN
CGEN
CPT
CPT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
60.5%
Q1 24
17.9%
Operating Margin
CGEN
CGEN
CPT
CPT
Q4 25
Q3 25
Q2 25
-475.1%
Q1 25
Q4 24
Q3 24
Q2 24
-128.5%
Q1 24
Net Margin
CGEN
CGEN
CPT
CPT
Q4 25
2954.1%
Q3 25
4246.9%
Q2 25
-410.1%
3063.8%
Q1 25
1561.0%
Q4 24
2642.3%
Q3 24
-246.3%
Q2 24
-101.4%
1646.9%
Q1 24
284.0%
6533.4%
EPS (diluted)
CGEN
CGEN
CPT
CPT
Q4 25
$1.44
Q3 25
$1.00
Q2 25
$-0.16
$0.74
Q1 25
$0.36
Q4 24
$0.37
Q3 24
$-0.04
Q2 24
$-0.10
$0.40
Q1 24
$89505618.00
$0.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGEN
CGEN
CPT
CPT
Cash + ST InvestmentsLiquidity on hand
$35.3M
$25.2M
Total DebtLower is stronger
$3.9B
Stockholders' EquityBook value
$50.3M
$4.4B
Total Assets
$106.5M
$9.0B
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGEN
CGEN
CPT
CPT
Q4 25
$25.2M
Q3 25
$25.9M
Q2 25
$35.3M
$33.1M
Q1 25
$26.2M
Q4 24
$21.0M
Q3 24
$31.2M
Q2 24
$44.6M
$93.9M
Q1 24
$39.3M
$92.7M
Total Debt
CGEN
CGEN
CPT
CPT
Q4 25
$3.9B
Q3 25
$3.7B
Q2 25
$3.8B
Q1 25
$3.7B
Q4 24
$3.5B
Q3 24
$3.5B
Q2 24
$3.6B
Q1 24
$3.6B
Stockholders' Equity
CGEN
CGEN
CPT
CPT
Q4 25
$4.4B
Q3 25
$4.5B
Q2 25
$50.3M
$4.6B
Q1 25
$4.6B
Q4 24
$4.7B
Q3 24
$4.7B
Q2 24
$58.3M
$4.9B
Q1 24
$65.6M
$4.9B
Total Assets
CGEN
CGEN
CPT
CPT
Q4 25
$9.0B
Q3 25
$9.1B
Q2 25
$106.5M
$9.1B
Q1 25
$9.0B
Q4 24
$8.9B
Q3 24
$8.9B
Q2 24
$110.2M
$9.1B
Q1 24
$121.3M
$9.1B
Debt / Equity
CGEN
CGEN
CPT
CPT
Q4 25
0.89×
Q3 25
0.82×
Q2 25
0.83×
Q1 25
0.81×
Q4 24
0.75×
Q3 24
0.73×
Q2 24
0.73×
Q1 24
0.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGEN
CGEN
CPT
CPT
Operating Cash FlowLast quarter
$-18.6M
$826.6M
Free Cash FlowOCF − Capex
$-18.8M
FCF MarginFCF / Revenue
-530.8%
Capex IntensityCapex / Revenue
6.5%
Cash ConversionOCF / Net Profit
5.30×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGEN
CGEN
CPT
CPT
Q4 25
$826.6M
Q3 25
$250.9M
Q2 25
$-18.6M
$230.7M
Q1 25
$148.2M
Q4 24
$774.9M
Q3 24
$261.6M
Q2 24
$39.7M
$225.1M
Q1 24
$135.9M
Free Cash Flow
CGEN
CGEN
CPT
CPT
Q4 25
Q3 25
Q2 25
$-18.8M
Q1 25
Q4 24
Q3 24
Q2 24
$39.7M
Q1 24
FCF Margin
CGEN
CGEN
CPT
CPT
Q4 25
Q3 25
Q2 25
-530.8%
Q1 25
Q4 24
Q3 24
Q2 24
428.3%
Q1 24
Capex Intensity
CGEN
CGEN
CPT
CPT
Q4 25
Q3 25
Q2 25
6.5%
Q1 25
Q4 24
Q3 24
Q2 24
0.4%
Q1 24
Cash Conversion
CGEN
CGEN
CPT
CPT
Q4 25
5.30×
Q3 25
2.30×
Q2 25
2.86×
Q1 25
3.82×
Q4 24
19.04×
Q3 24
Q2 24
5.24×
Q1 24
1.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons